CLOS
NVO

Compagnie Lombard Odier SCmA’s Novo Nordisk NVO Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$960K Sell
20,029
-751
-4% -$32.3K 0.01% 179
2026
Q1 		$764K Sell
20,780
-24,380
-54% -$1.16M 0.01% 175
2025
Q4 		$2.3M Sell
45,160
-675
-1% -$34.5K 0.03% 120
2025
Q3 		$2.54M Sell
45,835
-5,250
-10% -$307K 0.03% 121
2025
Q2 		$3.53M Sell
51,085
-12,145
-19% -$826K 0.05% 105
2025
Q1 		$4.39M Sell
63,230
-4,515
-7% -$373K 0.05% 108
2024
Q4 		$5.83M Buy
67,745
+3,200
+5% +$346K 0.09% 93
2024
Q3 		$7.69M Buy
64,545
+800
+1% +$107K 0.12% 83
2024
Q2 		$9.1M Sell
63,745
-85
-0.1% -$11.3K 0.15% 76
2024
Q1 		$8.2M Buy
63,830
+7,255
+13% +$864K 0.15% 88
2023
Q4 		$5.85M Buy
56,575
+8,665
+18% +$857K 0.11% 96
2023
Q3 		$4.36M Buy
47,910
+1,400
+3% +$123K 0.1% 98
2023
Q2 		$3.76M Buy
46,510
+22,010
+90% +$1.8M 0.11% 87
2023
Q1 		$1.95M Buy
24,500
+12,982
+113% +$921K 0.05% 130
2022
Q4 		$780K Sell
11,518
-1,200
-9% -$70.4K 0.02% 165
2022
Q3 		$634K Buy
+12,718
New +$681K 0.02% 194
2018
Q1 		– Sell
-100
Closed -$3K – 641
2017
Q4 		$3K Sell
100
-45,700
-100% -$1.16M ﹤0.01% 614
2017
Q3 		$1.1M Hold
45,800
– – 0.04% 206
2017
Q2 		$982K Sell
45,800
-2,800
-6% -$56.5K 0.03% 221
2017
Q1 		$833K Buy
+48,600
New +$846K 0.03% 233

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Compagnie Lombard Odier SCmA's NVO Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA reduced its Novo Nordisk (NVO) stake by 3.6% in Q2 2026, selling an estimated $32.3K and leaving 20,029 shares worth $960K. The position accounts for 0.01% of the portfolio, ranked #179.

Compagnie Lombard Odier SCmA first reported a position in NVO in Q1 2017 and has held it in 20 quarters since. The position peaked at $9.1M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Compagnie Lombard Odier SCmA held 20,029 shares of Novo Nordisk worth $960K as of Q2 2026.
  • Compagnie Lombard Odier SCmA sold 751 Novo Nordisk shares in Q2 2026, an estimated $32.3K.
  • Novo Nordisk made up 0.01% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #179 holding.
  • Compagnie Lombard Odier SCmA first reported a position in Novo Nordisk in Q1 2017 and has held it in 20 quarters since.
  • Compagnie Lombard Odier SCmA's Novo Nordisk position peaked at $9.1M in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.